Use of psychotropic drugs among older patients with bladder cancer in the United States.

摘要: OBJECTIVE Older patients diagnosed with cancer are at increased risk of physical and emotional distress; however, prescription utilization patterns largely remain to be elucidated. Our objective was comprehensively assess predictors in older bladder cancer. METHODS A total 10,516 clinical stage T1-T4a, N0, M0 urothelial carcinoma from 1 January 2008 31 December 2012 the Surveillance, Epidemiology, End Results (SEER)-Medicare were analyzed. We used multivariable analysis determine associated psychotropic rates (one or more). Medication possession ratio (MPR) as an index measure adherence intervals 3 months, 6 year, 2 years. Evaluation prescribing across different drugs demographic factors done. RESULTS Of patients, 5621 (53%) prescribed following diagnosis. Overall, 3972 (38%) had previous prescriptions prior diagnosis, these much more likely receive a post-cancer diagnosis prescription. Prescription for medications higher among BC (p < 0.001). Gamma aminobutyric acid modulators/stimulators serotonin reuptake inhibitors/stimulators highest 21% all patients. Adherence 32% months continued decrease over time. CONCLUSION Over half received within years their Given chronicity psychiatric disorders observed significantly low that warrants emphasis on prolonged patient monitoring further investigation.